BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

The Food and Drug Administration (FDA) expanded the approval of Moderna’s RSV vaccine late Thursday to include people 18 to ...

The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...

For a long time, scientists depended on luck to find new proteins. In 1840, for example, Friedrich Ludwig Hünefeld, a German ...

The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a welcome win.

Researchers in Australia use COVID-era mRNA technology to expose hidden HIV in white blood cells, offering hope for a future ...

President Trump’s administration has slammed the brakes on development of messenger RNA (mRNA) vaccines, which proved their lifesaving potential during the COVID-19 pandemic but have come ...

RNA gene scissors (CRISPR-Cas13) are gaining significant attention as a next-generation gene therapy with fewer side effects.

The BioNTech SE acquisition of CureVac N.V. brings together complementary technologies, as both are developing mRNA ...